Orally Disintegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia
Year: 2005
Type: article
Abstract: Article AbstractBecause this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.Sir: Kane et al., in their recent (January 2005) CME activity"Optimizing Pharmacotherapy to Maximize Outcome inSchizophrenia,"1 recommend using a long-acting depot injectionin patients who fail to adhere to antipsychotic treatment.While depot medications ensure compliance, they may not fostercertain aspects of the doctor-patient relationship, and evenwith depot medication, about 25% of patients stop keepingscheduled appointments and no longer receive depot injectionswithin 1 year after starting treatment.2 Furthermore, depotmedications may be associated with an increased risk for prolongedside effects.3†‹
Author: Frank L. Tornatore
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2014615390